secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-09-08T14:10:17+00:00
Accession:  0001493152-26-041725
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma rebrands as Aspire-Lakewood Holdings after Dura Control acquisition
--------------------------------------------------------------------------------

- Corporate name changed to Aspire-Lakewood Holdings, Inc.; effective upon Delaware Certificate of Amendment filing dated Sept 8, 2026.
- Nasdaq ticker symbol remains ASBP; no stockholder action required for the name change.
- CEO Kraig Higginson cites recent Dura Control Systems Corp. acquisition as the pivot to a diversified holding structure.
- DCSC subsidiary holds 310+ patents and operates 11 manufacturing facilities as a tier-one automotive supplier.
- Name change approved by board and stockholders under Delaware GCL Section 242.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226041725/0001493152-26-041725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226041725/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer